As discussed on the Fisher Clinical Services blog, last week I gave you my first 5 tips on what to consider when debating whether to monitor or control temperature sensitive supplies. If you missed that blog article, click here. This week I am pleased to give you my next 5 tips:
- Consider how established the monitoring system is: Monitoring systems that have been used thousands of times have not been proven to the same degree as those that have been used millions of times with very small failure rates. This collective data supports the monitoring systems validation. The longer and more widely a system has been successfully used reduces the risk of encountering problems in the adoption of any new monitor. This track-record of the system should be considered as well as the logistics management and support of such systems.
- Carry out your own analysis of shippers: Standard profiles to measure the efficiency of the shipper such as ISTA 7D or the one provided by the vendor may not reflect your own reality. It is best that you carry out your own analysis, and then make a cost comparison based on your own findings. Fisher Clinical Services manages a high volume of shipments globally. We know that no one system fits it all, despite claims by many vendors.
- Choose a trusted partner: The cold chain industry is one of high growth and revenue potential for many parties to the supply chain. Evaluate new entrants and err on the side of caution. Better to choose a partner with a track record of excellence in this industry rather than a new entrant from a different industry. Cold chain clinical logistics is a complex industry.
- Understand regulatory differences across borders: Whilst progress has been made in defining global regulations, the truth is that regulations and guidelines are often open to domestic or regional interpretation. Compliancy with local authorities is imperative and good documentation is key to showcasing compliance across the supply chain.
- Remember the patient: Over-engineering your cold chain management may not be the best way to go in terms of cost and efficacy, but the consequences of hurting a patient due to cold chain management failure is, without doubt, a much bigger loss.